Theravance Biopharma Inc (TBPH)
Cost of Revenue
$11.06M
TTM · Period ending: · USD
TBPH Cost of Revenue
Latest reported$11.06Mperiod ending
Latest reported$11.06Mperiod ending
TBPH TTM Cost of Revenue ($120.58M → $11.06M)
TTM cost of revenue
High-resolution chart · PNG
TBPH cost of revenue history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 11,061,000 | |
| 20,108,000 | |
| 31,560,000 | |
| 39,507,000 | |
| 40,663,000 | |
| 40,127,000 | |
| 37,643,000 | |
| 36,503,000 | |
| 28,574,000 | |
| 28,045,000 | |
| 33,649,000 | |
| 40,684,000 | |
| 49,212,000 | |
| 54,711,000 | |
| 63,392,000 | |
| 79,270,000 | |
| 113,142,000 | |
| 149,311,000 | |
| 193,657,000 | |
| 227,596,000 | |
| 183,857,000 | |
| 132,764,000 | |
| 65,165,000 | |
| 0 | |
| 52,006,000 | |
| 98,405,000 | |
| 152,223,000 | |
| 152,855,000 | |
| 101,554,000 | |
| 102,328,000 | |
| 49,336,000 | |
| 51,820,000 | |
| 52,100,000 | |
| 6,291,000 | |
| 6,030,000 | |
| 4,060,000 | |
| 3,407,000 | |
| 2,681,000 | |
| 2,894,000 | |
| 4,949,000 | |
| 5,198,000 | |
| 5,065,000 | |
| 4,658,000 | |
| 4,679,000 | |
| 4,467,000 | |
| 4,241,000 | |
| 4,058,000 | |
| 33,306,000 | |
| 65,238,000 | |
| 95,359,000 | |
| 120,579,000 | |
| 188,912,000 | |
| 156,611,000 |